1. Home
  2. TAOP vs BBLG Comparison

TAOP vs BBLG Comparison

Compare TAOP & BBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TAOP

Taoping Inc.

HOLD

Current Price

$1.33

Market Cap

2.9M

Sector

Technology

ML Signal

HOLD

BBLG

Bone Biologics Corp

HOLD

Current Price

$1.51

Market Cap

2.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TAOP
BBLG
Founded
1993
2004
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Industrial Specialties
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9M
2.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TAOP
BBLG
Price
$1.33
$1.51
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
75.8K
870.8K
Earning Date
12-08-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$36,196,786.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.19
$1.30
52 Week High
$20.10
$7.74

Technical Indicators

Market Signals
Indicator
TAOP
BBLG
Relative Strength Index (RSI) 28.93 33.35
Support Level $1.19 $1.76
Resistance Level $1.50 $2.39
Average True Range (ATR) 0.14 0.18
MACD -0.06 -0.05
Stochastic Oscillator 14.41 4.09

Price Performance

Historical Comparison
TAOP
BBLG

About TAOP Taoping Inc.

Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.

About BBLG Bone Biologics Corp

Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.

Share on Social Networks: